Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

325 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Rosuvastatin in older patients with systolic heart failure.
Kjekshus J, Apetrei E, Barrios V, Böhm M, Cleland JG, Cornel JH, Dunselman P, Fonseca C, Goudev A, Grande P, Gullestad L, Hjalmarson A, Hradec J, Jánosi A, Kamenský G, Komajda M, Korewicki J, Kuusi T, Mach F, Mareev V, McMurray JJ, Ranjith N, Schaufelberger M, Vanhaecke J, van Veldhuisen DJ, Waagstein F, Wedel H, Wikstrand J; CORONA Group. Kjekshus J, et al. Among authors: wedel h. N Engl J Med. 2007 Nov 29;357(22):2248-61. doi: 10.1056/NEJMoa0706201. Epub 2007 Nov 5. N Engl J Med. 2007. PMID: 17984166 Free article. Clinical Trial.
A statin in the treatment of heart failure? Controlled rosuvastatin multinational study in heart failure (CORONA): study design and baseline characteristics.
Kjekshus J, Dunselman P, Blideskog M, Eskilson C, Hjalmarson A, McMurray JV, Waagstein F, Wedel H, Wessman P, Wikstrand J; CORONA Study Group. Kjekshus J, et al. Among authors: wedel h. Eur J Heart Fail. 2005 Oct;7(6):1059-69. doi: 10.1016/j.ejheart.2005.09.005. Eur J Heart Fail. 2005. PMID: 16227145 Free article. Clinical Trial.
An economic evaluation of rosuvastatin treatment in systolic heart failure: evidence from the CORONA trial.
Lorgelly PK, Briggs AH, Wedel H, Dunselman P, Hjalmarson A, Kjekshus J, Waagstein F, Wikstrand J, Jánosi A, van Veldhuisen DJ, Barrios V, Fonseca C, McMurray JJ; CORONA Study Group. Lorgelly PK, et al. Among authors: wedel h. Eur J Heart Fail. 2010 Jan;12(1):66-74. doi: 10.1093/eurjhf/hfp172. Eur J Heart Fail. 2010. PMID: 20023047 Free PMC article. Clinical Trial.
Dose of metoprolol CR/XL and clinical outcomes in patients with heart failure: analysis of the experience in metoprolol CR/XL randomized intervention trial in chronic heart failure (MERIT-HF).
Wikstrand J, Hjalmarson A, Waagstein F, Fagerberg B, Goldstein S, Kjekshus J, Wedel H; MERIT-HF Study Group. Wikstrand J, et al. Among authors: wedel h. J Am Coll Cardiol. 2002 Aug 7;40(3):491-8. doi: 10.1016/s0735-1097(02)01970-8. J Am Coll Cardiol. 2002. PMID: 12142116 Free article. Clinical Trial.
What resting heart rate should one aim for when treating patients with heart failure with a beta-blocker? Experiences from the Metoprolol Controlled Release/Extended Release Randomized Intervention Trial in Chronic Heart Failure (MERIT-HF).
Gullestad L, Wikstrand J, Deedwania P, Hjalmarson A, Egstrup K, Elkayam U, Gottlieb S, Rashkow A, Wedel H, Bermann G, Kjekshus J; MERIT-HF Study Group. Gullestad L, et al. Among authors: wedel h. J Am Coll Cardiol. 2005 Jan 18;45(2):252-9. doi: 10.1016/j.jacc.2004.10.032. J Am Coll Cardiol. 2005. PMID: 15653024 Free article. Clinical Trial.
Predictors of fatal and non-fatal outcomes in the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA): incremental value of apolipoprotein A-1, high-sensitivity C-reactive peptide and N-terminal pro B-type natriuretic peptide.
Wedel H, McMurray JJ, Lindberg M, Wikstrand J, Cleland JG, Cornel JH, Dunselman P, Hjalmarson A, Kjekshus J, Komajda M, Kuusi T, Vanhaecke J, Waagstein F; CORONA Study Group. Wedel H, et al. Eur J Heart Fail. 2009 Mar;11(3):281-91. doi: 10.1093/eurjhf/hfn046. Epub 2009 Jan 24. Eur J Heart Fail. 2009. PMID: 19168876 Free PMC article. Clinical Trial.
How should subgroup analyses affect clinical practice? Insights from the Metoprolol Succinate Controlled-Release/Extended-Release Randomized Intervention Trial in Heart Failure (MERIT-HF).
Wikstrand J, Wedel H, Ghali J, Deedwania P, Fagerberg B, Goldstein S, Gottlieb S, Hjalmarson A, Kjekshus J, Waagstein F. Wikstrand J, et al. Among authors: wedel h. Card Electrophysiol Rev. 2003 Sep;7(3):264-75. doi: 10.1023/B:CEPR.0000012438.04416.00. Card Electrophysiol Rev. 2003. PMID: 14739726
Presence and development of atrial fibrillation in chronic heart failure. Experiences from the MERIT-HF Study.
van Veldhuisen DJ, Aass H, El Allaf D, Dunselman PH, Gullestad L, Halinen M, Kjekshus J, Ohlsson L, Wedel H, Wikstrand J; MERIT-HF Study Group. van Veldhuisen DJ, et al. Among authors: wedel h. Eur J Heart Fail. 2006 Aug;8(5):539-46. doi: 10.1016/j.ejheart.2006.01.015. Epub 2006 Mar 29. Eur J Heart Fail. 2006. PMID: 16567126 Free article. Clinical Trial.
The influence of renal function on clinical outcome and response to beta-blockade in systolic heart failure: insights from Metoprolol CR/XL Randomized Intervention Trial in Chronic HF (MERIT-HF).
Ghali JK, Wikstrand J, Van Veldhuisen DJ, Fagerberg B, Goldstein S, Hjalmarson A, Johansson P, Kjekshus J, Ohlsson L, Samuelsson O, Waagstein F, Wedel H; MERIT-HF Study Group. Ghali JK, et al. Among authors: wedel h. J Card Fail. 2009 May;15(4):310-8. doi: 10.1016/j.cardfail.2008.11.003. Epub 2008 Dec 23. J Card Fail. 2009. PMID: 19398079 Clinical Trial.
325 results